Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities:
Net income	$ 841,454	$ 2,652,017
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	416,177	289,405
Amortization of operating right of use asset	40,239	0
Stock compensation expense	244,505	323,273
Bad debt expense	250,000	200,000
(Increase) decrease in:
Accounts receivables	(231,438)	208,051
Long-term receivables, prepaid and other assets	665,474	(1,892,581)
(Decrease) increase in:
Accounts payable	225,970	(652,283)
Operating Lease liability	(40,239)	0
Accrued liabilities	(284,418)	366,966
Deferred revenue	543,861	335,734
Net cash provided by operating activities	2,671,585	1,830,582
Cash Flows from Investing Activities:
Purchase of property and equipment	(581,750)	(3,547)
Net cash used in investing activities	(581,750)	(3,547)
Cash Flows from Financing Activities:
Net increase in lines of credit	0	(1,430,000)
Proceeds from exercise of warrants	0	164,977
Common Stock buyback/retirement	(1,355,037)	0
Proceeds from employee stock plan	63,523	0
Dividends paid	(293,222)	(146,611)
Payments on notes payable and capital leases	(145,747)	(1,485,578)
Net cash used in financing activities	(1,730,483)	(37,192)
Net increase in cash and cash equivalents	359,352	1,789,843
Cash and cash equivalents at beginning of period	18,609,423	14,892,439
Cash and cash equivalents at end of period	18,968,775	16,682,282
Supplemental disclosure of cash flow information:
Cash paid for income taxes	100,158	47,500
Cash paid for interest	16,042	5,622
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities	155,325	253,017
Dividends accrued on preferred stock	293,222	293,222
Right of use asset	$ 842,689	$ 0